MILLENNIUM MANAGEMENT LLC Increases Stake in ARS Pharmaceuticals, Inc.

Millennium Management LLC, along with affiliated entities Integrated Core Strategies (US) LLC and Millennium Group Management LLC, and individual Israel A. Englander, have jointly filed a Schedule 13G/A amendment, increasing their collective beneficial ownership of ARS Pharmaceuticals, Inc. common stock to 6.0%. This filing, dated March 30, 2026, reflects an increase in shares to 5,916,030 from a previous 5,391,440. The total value of the holding is approximately $46.3 million. The filing asserts that these securities were not acquired or held for the purpose of influencing the control of the issuer. The reporting entities are all Delaware-based, with their principal offices located at 399 Park Avenue, New York, NY 10022. Israel A. Englander is a U.S. citizen.